The pharmaceutical supply chain is a complex network that involves multiple stages, from the sourcing of raw materials to the distribution of finished products, all while ensuring compliance with stringent regulatory standards. It begins with the procurement of active pharmaceutical ingredients (APIs) from manufacturers, followed by formulation processes where these APIs are combined with excipients to create the final dosage forms, such as tablets, capsules, or injections. Quality control is critical at each phase, ensuring safety and efficacy throughout. Once produced, the products are packaged and stored in controlled conditions before being distributed to wholesalers, pharmacies, hospitals, and ultimately to patients. This process also encompasses managing logistics, inventory control, and real-time tracking to prevent drug shortages and counterfeiting, while advances in technology, such as blockchain and IoT, are increasingly being integrated to enhance transparency and efficiency. Additionally, global trade dynamics, regulatory variances across countries, and the recent impact of the COVID-19 pandemic have underscored the need for resilience and adaptability within the pharmaceutical supply chain, emphasizing the importance of strategic partnerships and risk management to navigate an ever-evolving landscape.